Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | APAF1 | O14727 | 1/20 | 0.53 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.53 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.53 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.53 |
| ▸ | FDPS | P14324 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | PON1 | P27169 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL6116136 | 0.98 | SMN1; SMN2 (0.56) | SMN1; SMN2MEN1APAF1NPC1PLA2G1B | |
| SCHEMBL16674008 | 0.90 | SMN1; SMN2 (0.53) | SMN1; SMN2MEN1APAF1NPC1PLA2G1B | |
| SCHEMBL2520923 | 0.89 | SMN1; SMN2 (0.59) | SMN1; SMN2MEN1APAF1NPC1PLA2G1B | |
| SCHEMBL12936199 | 0.89 | SMN1; SMN2 (0.58) | SMN1; SMN2MEN1APAF1NPC1PLA2G1B | |
| SCHEMBL2519180 | 0.87 | SMN1; SMN2 (0.62) | SMN1; SMN2MEN1APAF1NPC1PLA2G1B | |
| Hydrochloric Acid SCHEMBL16713772 | 0.87 | SMN1; SMN2 (0.56) | SMN1; SMN2MEN1APAF1NPC1PLA2G1B | |
| SCHEMBL12936202 | 0.87 | SMN1; SMN2 (0.56) | SMN1; SMN2MEN1APAF1NPC1PLA2G1B | |
| SCHEMBL17418620 | 0.84 | SMN1; SMN2 (0.40) | SMN1; SMN2MEN1APAF1NPC1PLA2G1B | |
| SCHEMBL4893845 | 0.83 | MEN1 (0.47) | SMN1; SMN2MEN1APAF1NPC1PLA2G1B | |
| SCHEMBL26695497 | 0.83 | SMN1; SMN2 (0.51) | SMN1; SMN2MEN1APAF1NPC1PLA2G1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8921589-B2 | Electrolyte formulations | MERCK PATENT GMBH (DE) | 2014-12-30 | — | — | US | claimed |
| US-8864883-B2 | Surface treatments for dessicant media in a water recovery device | Z124 (KY) | 2014-10-21 | — | — | US | claimed |
| US-8829201-B2 | Electrolyte Formulations | MERCK PATENT GMBH (DE) | 2014-09-09 | — | — | US | claimed |
| US-8808424-B2 | Apparatus and method for removing CO2 from a production plant discharge | MUNTERS CORPORATION (US) | 2014-08-19 | — | — | US | claimed |
| EP-2673068-A1 | Apparatus and method for removing co2 from a production plant discharge | Munters Corporation (US) | 2013-12-18 | — | — | EP | claimed |
| US-20130319022-A1 | SURFACE TREATMENTS FOR DESSICANT MEDIA IN A WATER RECOVERY DEVICE | Z124 (KY) | 2013-12-05 | — | — | US | claimed |
| US-20120318360-A1 | Electrolyte Formulations | MERCK PATENT GMBH (DE) | 2012-12-20 | — | — | US | claimed |
| US-20120204717-A1 | APPARATUS AND METHOD FOR REMOVING CO2 FROM A PRODUCTION PLANT DISCHARGE | MUNTERS CORPORATION (US) | 2012-08-16 | — | — | US | claimed |
| WO-2012109547-A1 | APPARATUS AND METHOD FOR REMOVING CO2 FROM A PRODUCTION PLANT DISCHARGE | MUNTERS CORPORATION (US) | 2012-08-16 | — | — | WO | claimed |
| US-20110247494-A1 | LIQUID SORBANT, METHOD OF USING A LIQUID SORBANT, AND DEVICE FOR SORBING A GAS | VTU Holding GmbH. (AT) | 2011-10-13 | — | — | US | claimed |
| US-20250122323-A1 | ONIUM SALT, BLOCKING AGENT DISSOCIATION CATALYST FOR BLOCKED ISOCYANATE, BLOCKED ISOCYANTE COMPOSITION INCLUDING BLOCKING AGENT DISSOCIATION CATALYST, THERMOSETTING RESIN COMPOSITION, AND CURED PRODUCT AND MANUFACTURING METHOD THEREFOR | KOEI CHEMICAL COMPANY, LIMITED (JP) | 2025-04-17 | — | — | US | disclosed |
| US-20250122322-A1 | ZWITTERIONIC COMPOUND, AND BLOCKING AGENT DISSOCIATION CATALYST FOR BLOCKED ISOCYANATE, BLOCKED ISOCYANATE COMPOSITION CONTAINING BLOCKING AGENT DISSOCIATION CATALYST, THERMOSETTING RESIN COMPOSITION, CURED PRODUCT AND METHOD FOR MANUFACTURING SAME, AND CARBONATE COMPOUND | KOEI CHEMICAL COMPANY, LIMITED (JP) | 2025-04-17 | — | — | US | disclosed |
| CN-117946544-B | Graphene premix, coating composition, and coated article | 宣伟(南通)涂料有限公司 | 2024-12-17 | — | — | CN | disclosed |
| CN-117946544-A | Graphene premix, coating composition, and coated article | 宣伟(南通)涂料有限公司 | 2024-04-30 | — | — | CN | disclosed |
| CN-117813334-A | Onium salt, blocking agent dissociation catalyst for blocking isocyanate, blocked isocyanate composition containing blocking agent dissociation catalyst, thermosetting resin composition, cured product, and method for producing same | 广荣化学株式会社 | 2024-04-02 | — | — | CN | disclosed |
| US-20110247494-A1 | LIQUID SORBANT, METHOD OF USING A LIQUID SORBANT, AND DEVICE FOR SORBING A GAS | VTU Holding GmbH. (AT) | 2011-10-13 | — | — | US | disclosed |
| WO-2011085965-A1 | ELECTROLYTE FORMULATIONS | MERCK PATENT GMBH (DE) | 2011-07-21 | — | — | WO | disclosed |
| WO-2011085964-A1 | ELECTROLYTE FORMULATIONS | MERCK PATENT GMBH (DE) | 2011-07-21 | — | — | WO | disclosed |
| WO-2011085967-A1 | COMPOUNDS CONTAINING PERFLUOROALKYL-CYANO-ALKOXY-BORATE ANIONS OR PERFLUOROALKYL-CYANO-ALKOXY-FLUORO-BORATE ANIONS | MERCK PATENT GMBH (DE) | 2011-07-21 | — | — | WO | disclosed |
| US-20060186419-A1 | Light-emitting device | KABUSHIKI KAISHA TOSHIBA (JP) | 2006-08-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120318360-A1 | Electrolyte Formulations | NHERF1, HCN4, DDT | SMN1; SMN2 4519/4885MEN1 1923/4885APAF1 4563/4885 |
| US-20250122322-A1 | ZWITTERIONIC COMPOUND, AND BLOCKING AGENT DISSOCIATION CATALYST FOR BLOCKED ISOCYANATE, BLOCKED ISOCYANATE COMPOSITION CONTAINING BLOCKING AGENT DISSOCIATION CATALYST, THERMOSETTING RESIN COMPOSITION, CURED PRODUCT AND METHOD FOR MANUFACTURING SAME, AND CARBONATE COMPOUND | RCC1, KDM2B, RB1 | SMN1; SMN2 2224/4885MEN1 257/4885APAF1 4029/4885 |
| US-20250122323-A1 | ONIUM SALT, BLOCKING AGENT DISSOCIATION CATALYST FOR BLOCKED ISOCYANATE, BLOCKED ISOCYANTE COMPOSITION INCLUDING BLOCKING AGENT DISSOCIATION CATALYST, THERMOSETTING RESIN COMPOSITION, AND CURED PRODUCT AND MANUFACTURING METHOD THEREFOR | KDM2B, O60361, IDH3B | SMN1; SMN2 2709/4885MEN1 1391/4885APAF1 3730/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.